Natallizumab treatment | Number of patients | Group | False labeling pattern |
---|
Yes
| 20 | 2 | 17* |
No
| 147 | 1-6 | 0 |
- *These patients were on natalizumab at the time blood samples were taken or stopped receiving this drug less than 6 months prior to collection of the blood sample.